Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany-Reference-Cited by-同舟云学术

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany

Published:2018-01 Issue: Volume:268 Page:99-107
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

März Winfried,Dippel Franz-Werner,Theobald Karlheinz,Gorcyca Katherine,Iorga Şerban R.,Ansell David

Funder

Aegerion Pharmaceuticals

Amgen

AstraZeneca

Danone Research

Sanofi/Genzyme

Pfizer

BASF

Hoffmann LaRoche

MSD

Sanofi. D.A.

Sanofi and Regeneron Pharmaceuticals, Inc

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Cardiovascular disease in Europe: epidemiological update 2016;Townsend;Eur. Heart J.,2016

2. Noncommunicables Disease (NCS) Country Profiles: Germany;World Health Organization,2014

3. N. European Cardiovascular Disease Statistics 2017;Wilkins,2017

4. 2016 ESC/EAS Guidelines for the management of dyslipidaemias;Catapano;Eur. Heart J.,2016

5. 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines;Stone;Circulation,2014

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-lowering therapy in patients with coronary heart disease: an Italian real-life survey. Results from the Survey on Risk FactOrs and CardiovascuLar secondary prEvention and drug strategieS (SOFOCLES) in Italy;Monaldi Archives for Chest Disease;2024-09-10

2. Empfehlungen zum Lipidmanagement;Aktuelle Kardiologie;2024-07-31

3. Guideline-Directed Low-Density Lipoprotein Cholesterol Management After Acute Ischemic Stroke: Findings from a National Health Care Service;The American Journal of Cardiology;2023-09

4. Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population;International Journal of Cardiology Cardiovascular Risk and Prevention;2023-09

5. Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update;Metabolites;2023-08-04